Cargando…

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.

Adriamycin and cyclophosphamide are active agents in human and experimental tumours. Using the L1210 murine leukaemia, their effectiveness alone and in combination was studied. The combination is highly synergistic in this tumour, resulting in a greater than 50% survival rate when the agents used al...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobias, J. S., Parker, L. M., Tattersall, M. H., Frei, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1975
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024893/
https://www.ncbi.nlm.nih.gov/pubmed/1212350